"The upright freelancers biotech and small industries are, in some respects, as the old drug behemoth company divisions, but only connected by tendrils of the Internet and the relationships that grow so easily." Rienhoff is the response of modern biotechnology in the lost Renaissance man. It is the effect renaissance outside the network around him, with the terrible complexity of the world community to fight against the terrible complexity of the disease. This is how science should work. »
An interesting, if "anemic", article on FerroKin, a virtual drug of the company in development of chelating agents to treat excess iron due to blood transfusions (fixing the fix, I guess).
Drug Developer virtual second, I've heard. In the high technology programs, virtual managers are common, development of products through different companies - encoder, hardware design, production, distribution. No reason to believe that we cannot do in biotechnology. Especially with all the tools of communication available.